IRE1-dependent activation of AMPK in response to nitric oxide

Mol Cell Biol. 2011 Nov;31(21):4286-97. doi: 10.1128/MCB.05668-11. Epub 2011 Sep 6.

Abstract

While there can be detrimental consequences of nitric oxide production at pathological concentrations, eukaryotic cells have evolved protective mechanisms to defend themselves against this damage. The unfolded-protein response (UPR), activated by misfolded proteins and oxidative stress, is one adaptive mechanism that is employed to protect cells from stress. Nitric oxide is a potent activator of AMP-activated protein kinase (AMPK), and AMPK participates in the cellular defense against nitric oxide-mediated damage in pancreatic β-cells. In this study, the mechanism of AMPK activation by nitric oxide was explored. The known AMPK kinases LKB1, CaMKK, and TAK1 are not required for the activation of AMPK by nitric oxide. Instead, this activation is dependent on the endoplasmic reticulum (ER) stress-activated protein IRE1. Nitric oxide-induced AMPK phosphorylation and subsequent signaling to AMPK substrates, including Raptor, acetyl coenzyme A carboxylase, and PGC-1α, is attenuated in IRE1α-deficient cells. The endoribonuclease activity of IRE1 appears to be required for AMPK activation in response to nitric oxide. In addition to nitric oxide, stimulation of IRE1 endoribonuclease activity with the flavonol quercetin leads to IRE1-dependent AMPK activation. These findings indicate that the RNase activity of IRE1 participates in AMPK activation and subsequent signaling through multiple AMPK-dependent pathways in response to nitrosative stress.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinase Kinases
  • AMP-Activated Protein Kinases / antagonists & inhibitors
  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism*
  • Animals
  • Calcium-Calmodulin-Dependent Protein Kinase Kinase / metabolism
  • Cell Line
  • Endoplasmic Reticulum Stress
  • Endoribonucleases / deficiency
  • Endoribonucleases / genetics
  • Endoribonucleases / metabolism*
  • Enzyme Activation / drug effects
  • Gene Knockdown Techniques
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism
  • MAP Kinase Kinase Kinases / metabolism
  • Mechanistic Target of Rapamycin Complex 1
  • Membrane Proteins / metabolism*
  • Mice
  • Models, Biological
  • Multiprotein Complexes
  • Nitric Oxide / pharmacology
  • Protein Serine-Threonine Kinases / deficiency
  • Protein Serine-Threonine Kinases / genetics
  • Protein Serine-Threonine Kinases / metabolism*
  • Proteins / antagonists & inhibitors
  • RNA, Small Interfering / genetics
  • Rats
  • Signal Transduction
  • TOR Serine-Threonine Kinases

Substances

  • Membrane Proteins
  • Multiprotein Complexes
  • Proteins
  • RNA, Small Interfering
  • Nitric Oxide
  • Ern2 protein, rat
  • Ern1 protein, mouse
  • Mechanistic Target of Rapamycin Complex 1
  • Protein Serine-Threonine Kinases
  • Stk11 protein, rat
  • TOR Serine-Threonine Kinases
  • Calcium-Calmodulin-Dependent Protein Kinase Kinase
  • MAP Kinase Kinase Kinases
  • MAP kinase kinase kinase 7
  • AMP-Activated Protein Kinase Kinases
  • AMP-Activated Protein Kinases
  • Endoribonucleases